Tissue Regenix was founded in May 2006, to commercialise innovative technologies in regenerative medicine. The underpinning science was developed over the last decade in the world-leading Institute for Medical and Biological Engineering at the University of Leeds by Professors John Fisher and Eileen Ingham. The research has received in excess of Â£4 million grant funding to date from UK research councils (EPSRC, BBSRC) and the Children's Heart Surgery Fund.
Funding Rounds (1) - $1.35MUpdate
|Apr 30, 2010||whiteroseseedcorn.com - Tissue Regenix raises 1349658 in unknown round|
Innovation Way, Heslington
York, YO10 5NY